Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

PUMA BIOTECHNOLOGY, INC.

(PBYI)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Puma Biotechnology, Inc. Appoints Allison Dorval to the Board of Directors and Audit Committee of the Board

07/14/2021 | 04:06pm EDT

On July 8, 2021, Allison Dorval, 45, was appointed to the Board of Directors (the Board") of Puma Biotechnology, Inc., effective July 15, 2021. Ms. Dorval will serve on the Board for a term expiring at the 2022 Annual Meeting of Stockholders and until her successor is duly elected and qualified, or until her earlier death, resignation or removal. In connection with her appointment to the Board, Ms. Dorval was also appointed to the Audit Committee of the Board (the Audit Committee"). Ms. Dorval has served as the Chief Financial Officer of Voyager Therapeutics, Inc., since November 2018 and as Voyager's principal financial officer and principal accounting officer since June 2018.


ę S&P Capital IQ 2021
All news about PUMA BIOTECHNOLOGY, INC.
09/07PUMA BIOTECHNOLOGY : Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)..
BU
09/07PUMA BIOTECHNOLOGY : to Present at the H.C. Wainwright 23rd Annual Global Invest..
BU
08/06PUMA BIOTECHNOLOGY : Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)..
BU
08/06PUMA BIOTECHNOLOGY : RBC Cuts PT on Puma Biotechnology to $6 From $13, Citing Ne..
MT
08/05PUMA BIOTECH : Q2 Earnings Snapshot
AQ
08/05PUMA BIOTECHNOLOGY : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION..
AQ
08/05PUMA BIOTECHNOLOGY : Reports Second Quarter 2021 Financial Results
BU
08/05PUMA BIOTECHNOLOGY, INC. : Results of Operations and Financial Condition, Financ..
AQ
08/05Puma Biotechnology, Inc. Reports Earnings Results for the Second Quarter Ende..
CI
08/05PUMA BIOTECHNOLOGY : Earnings Flash (PBYI) PUMA BIOTECHNOLOGY Reports Q2 EPS $0...
MT
More news
Analyst Recommendations on PUMA BIOTECHNOLOGY, INC.
More recommendations
Financials (USD)
Sales 2021 266 M - -
Net income 2021 -1,69 M - -
Net cash 2021 54,4 M - -
P/E ratio 2021 -27,9x
Yield 2021 -
Capitalization 281 M 281 M -
EV / Sales 2021 0,85x
EV / Sales 2022 0,88x
Nbr of Employees 267
Free-Float 86,6%
Chart PUMA BIOTECHNOLOGY, INC.
Duration : Period :
Puma Biotechnology, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PUMA BIOTECHNOLOGY, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 9
Last Close Price 6,90 $
Average target price 8,63 $
Spread / Average Target 25,0%
EPS Revisions
Managers and Directors
Alan H. Auerbach Chairman, President, CEO & Secretary
Maximo F. Nougues Chief Financial Officer
Jay M. Moyes Lead Independent Director
Troy E. Wilson Independent Director
Adrian M. Senderowicz Independent Director
Sector and Competitors
1st jan.Capi. (M$)
PUMA BIOTECHNOLOGY, INC.-32.75%281
MODERNA, INC.311.65%173 588
LONZA GROUP AG32.35%60 074
IQVIA HOLDINGS INC.43.07%49 116
CELLTRION, INC.-23.26%31 904
SEAGEN INC.-10.81%28 420